BioSig Technologies, Inc. announced that it is advancing the research and development of an artificial intelligence (AI) medical device platform in collaboration with technical advisory partner Reified Labs. The platform's foundational machine learning model is anticipated to be based on integrated healthcare datasets, beginning with ECG and IECG data acquired by BioSig's first product, the PURE EP� Platform.
Electrophysiology-focused technological solutions developed under the terms of the collaboration may be integrated into PURE EP� technology for potential commercial application.